Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4273087 | The Journal of Sexual Medicine | 2009 | 14 Pages |
Abstract
An overall equivalence was demonstrated in the subjective perception of treatment benefits for all the PDE5i tested. However, sildenafil, in a dose-dependent manner, was the unique PDE5i able to ameliorate some of the penile flow parameters within the 8-week treatment period. These findings should be interpreted conservatively because of the observational nature of the study. Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata ARM, Maggi M, Mansani R, Palego P, Spera G, Vetri M, and Lenzi A on behalf of the Endotrial Study Group. The ENDOTRIAL study: A spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J Sex Med 2009;6:2547-2560.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Emmanuele A. MD, Andrea M. MD, PhD, Giovanni Luca MD, PhD, Antonio MD, PhD, Giancarlo MD, Massimo MD, Marco MD, Cesare MD, Giovanni MD, Andrea MD, PhD, Carlo MD, Gianni MD, Sandro MD, Antonio R.M. PhD, Mario MD, PhD, Riccardo MD, Pierfrancesco MD,